BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10488103)

  • 1. Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest.
    Knudsen KE; Fribourg AF; Strobeck MW; Blanchard JM; Knudsen ES
    J Biol Chem; 1999 Sep; 274(39):27632-41. PubMed ID: 10488103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression.
    Knudsen ES; Buckmaster C; Chen TT; Feramisco JR; Wang JY
    Genes Dev; 1998 Aug; 12(15):2278-92. PubMed ID: 9694794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
    Strobeck MW; Fribourg AF; Puga A; Knudsen ES
    Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
    Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
    Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis.
    Shen WH; Yin Y; Broussard SR; McCusker RH; Freund GG; Dantzer R; Kelley KW
    J Biol Chem; 2004 Feb; 279(9):7438-46. PubMed ID: 14681231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active RB elicits late G1/S inhibition.
    Angus SP; Fribourg AF; Markey MP; Williams SL; Horn HF; DeGregori J; Kowalik TF; Fukasawa K; Knudsen ES
    Exp Cell Res; 2002 Jun; 276(2):201-13. PubMed ID: 12027450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition.
    Zhang HS; Postigo AA; Dean DC
    Cell; 1999 Apr; 97(1):53-61. PubMed ID: 10199402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
    Wang S; Nath N; Minden A; Chellappan S
    EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.
    Zhang HS; Gavin M; Dahiya A; Postigo AA; Ma D; Luo RX; Harbour JW; Dean DC
    Cell; 2000 Mar; 101(1):79-89. PubMed ID: 10778858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
    Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p16 in the E2F-dependent thymidine kinase regulation.
    Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
    Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of BRCA1 expression by the Rb-E2F pathway.
    Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
    J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.